查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1673055

按产品类型、治疗领域、应用和地区分類的配药市场

Compounding Pharmacies Market, By Product Type, By Therapeutic Area, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球复合药局市场规模估计为 118.9 亿美元，预计到 2032 年将达到 182.4 亿美元，2025 年至 2032 年的复合年增长率为 6.3%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 118.9亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 6.30% 2032 年金额预测 182.4亿美元
数字。 2025 年各地区配药市场占有率（%）
复合药局市场-IMG1

由于针对复杂情况的个人化药物的需求不断增加，全球复合药局市场预计将在预测期内呈指数级增长。当食品药物管理局核准处方笺美国时，配药药房会根据患者的特定临床需求组合和修改成分，以创建定製配方。这些有助于解决精确的剂量要求和特殊配方，例如针对无法吞嚥固态锭剂的儿童或老年患者的药物。此外，配药商可以生产具有独特风味和给药途径的药物，扩大治疗选择。越来越多的老年人被诊断出患有慢性疾病，推动了处方药的需求。

市场动态

由于全球需要客製化药物的慢性病发病率不断增加，全球复合药局市场正经历强劲成长。此外，老年人口的不断增长，往往需要专门的配方和剂型，这也推动了市场的成长。配药药房相对于非处方药的优势，例如独特的剂型、儿科剂型以及满足特定患者需求的能力，也在推动市场成长。然而，严格的处方药法规结构和品质标准可能会阻碍市场的成长。此外，昂贵的商业等价物的供应也可能阻碍市场的成长。新兴经济体医疗保健支出的增加和先进复合技术的利用可能为市场成长提供有利的机会。

研究的主要特点

  • 本报告对全球配药药房市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和复合年增长率（CAGR%），以 2024 年为基准年。
  • 它揭示了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球配药药局市场的主要企业。
  • 主要企业包括 Avella Specialty Pharmacy、Central Admixture Pharmacy Services、Fagron、Fresenius Kabi AG、PharMEDium Services、Institutional Pharmacy Solutions、Cantrell Drug Company、Triangle Compounding Pharmacies、Lorraine's Pharmacy、Rx3 Compounding Pharmacy、Ban BraLC​​ing Pharmacies、Lorraine's Pharmacy、Rx3 Compounding Pharmacy、BBB.k、B错误、Scocy0、Saken Pharmacy00000 NpiniS、BasSa)。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球复合药房市场迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过分析全球药局市场所使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章 全球药局市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020-2032 年全球复合药局市场（按产品类型划分）（十亿美元）

  • 介绍
  • 口服
  • 胶囊
  • 锭剂
  • 混合物
  • 糖果
  • 锭剂
  • 局部的
  • 凝胶
  • 软膏
  • 奶油
  • 洗剂
  • 直肠
  • 鼻腔
  • 眼科

6. 2020-2032 年全球复合药局市场按治疗领域划分（十亿美元）

  • 介绍
  • 荷尔蒙补充疗法
  • 疼痛管理
  • 专科药物
  • 营养补充品
  • 其他的

7. 2020 年至 2032 年全球配药药房市场（按应用划分）（十亿美元）

  • 介绍
  • 孩子们
  • 成人
  • 老年人
  • 兽医

8. 2020-2032 年全球配药药房市场（按地区划分）（单位：十亿美元）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Avella Specialty Pharmacy
    • Central Admixture Pharmacy Services
    • Fagron
    • Fresenius Kabi AG
    • PharMEDium Services
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Triangle Compounding Pharmacies
    • Lorraine's Pharmacy
    • Rx3 Compounding Pharmacy
    • B Braun SE
    • Clinigen Group PLC
    • QuVa Pharma
    • ITC Compounding Pharmacy
    • Advanced Pharmacy
    • Myonex

第 10 章分析师建议

  • 兴衰
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI3199

Global Compounding Pharmacies Market is estimated to be valued at USD 11.89 Bn in 2025 and is expected to reach USD 18.24 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.89 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.30% 2032 Value Projection: USD 18.24 Bn
Figure. Compounding Pharmacies Market Share (%), By Region 2025
Compounding Pharmacies Market - IMG1

Global compounding pharmacies market is expected to witness growth exponentially over the forecast period, owing to rising demand for personalized medications for complex conditions. Compounding pharmacies combine or alter ingredients into customized formulations as per patient's specific clinical needs when an U.S. Food and Drug Administration approved prescription product is not available. These help to cater accurate dosing requirements and particular formulations like medications for pediatric or geriatric patients who cannot swallow solid pills. Moreover, the ability of compounders to produce medications with unique flavors and routes of administration expands treatment options. Growing geriatric population diagnosed with chronic health conditions boosts demand for compounded medications.

Market Dynamics:

Global compounding pharmacies market is witnessing robust growth due to increasing incidence of chronic medical conditions worldwide requiring customized medications. Moreover, growing geriatric population base that often need specialized formulations and dose forms of drugs can drive the market growth The advantages of compounding pharmacies over commercially available drugs including unique dosage forms, pediatric dose forms, and ability to cater to patient-specific needs can also drive the market growth. However, strict regulatory framework and quality standards for compounded drugs can hamper the market growth. The availability of expensive commercial equivalents can also hamper the market growth. Increasing healthcare expenditure in emerging nations and utilization of advanced technologies in compounding can offer lucrative opportunities for the market growth.

Key Features of the Study:

  • This report provides an in-depth analysis of the global compounding pharmacies market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global compounding pharmacies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine's Pharmacy, Rx3 Compounding Pharmacy, B Braun SE, Clinigen Group PLC, QuVa Pharma, ITC Compounding Pharmacy, Advanced Pharmacy.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global compounding pharmacies market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding pharmacies market.

Detailed Segmentation-

  • By Product Type:
    • Oral
    • Capsule
    • Tablets
    • Mixtures
    • Lollipops
    • Lozenges
    • Topical
    • Gels
    • Ointments
    • Cream
    • Lotions
    • Rectal
    • Nasal
    • Ophthalmic
  • By Therapeutic Area:
    • Hormone Replacement Therapy
    • Pain Management
    • Specialty Drugs
    • Nutritional Supplements
    • Others
  • By Application:
    • Pediatric
    • Adults
    • Geriatrics
    • Veterinary
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Avella Specialty Pharmacy
    • Central Admixture Pharmacy Services
    • Fagron
    • Fresenius Kabi AG
    • PharMEDium Services
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Triangle Compounding Pharmacies
    • Lorraine's Pharmacy
    • Rx3 Compounding Pharmacy
    • B Braun SE
    • Clinigen Group PLC
    • QuVa Pharma
    • ITC Compounding Pharmacy
    • Advanced Pharmacy

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Compounding Pharmacies Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Compounding Pharmacies Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Capsule
  • Tablets
  • Mixtures
  • Lollipops
  • Lozenges
  • Topical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gels
  • Ointments
  • Cream
  • Lotions
  • Rectal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nasal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ophthalmic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Compounding Pharmacies Market, By Therapeutic Area, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hormone Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pain Management
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nutritional Supplements
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Compounding Pharmacies Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pediatric
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Adults
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Veterinary
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Compounding Pharmacies Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Avella Specialty Pharmacy
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Central Admixture Pharmacy Services
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fagron
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fresenius Kabi AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PharMEDium Services
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Triangle Compounding Pharmacies
    • Lorraine's Pharmacy
    • Rx3 Compounding Pharmacy
    • B Braun SE
    • Clinigen Group PLC
    • QuVa Pharma
    • ITC Compounding Pharmacy
    • Advanced Pharmacy
    • Myonex

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact